Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T01:52:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a clinical trial involving copanlisib and nivolumab for treating relapsed/refractory diffuse large B-cell lymphoma, while adding new identifiers and a revision number.
    Difference
    59%
    Check dated 2025-04-16T14:19:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 3, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T08:55:48.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 3, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T23:07:42.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:48:45.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has updated several important dates, including the addition of specific dates in 2025 and the removal of previous estimated dates.
    Difference
    0.7%
    Check dated 2025-03-03T23:55:07.000Z thumbnail image

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.